Neurogene
NGNE
NGNE
50 hedge funds and large institutions have $302M invested in Neurogene in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
21
Reduced
12
Closed
9
Calls
$2.33M
Puts
$4.24M
Net Calls
-$1.91M
Net Calls Change
-$1.99M
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$6.12M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.07M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.52M |
| 4 |
Morgan Stanley
New York
|
+$1.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$806K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$11.3M |
| 2 |
BlackRock
New York
|
-$3M |
| 3 |
AC
Ascend Capital
Orinda,
California
|
-$2.54M |
| 4 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$1.59M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |
